Swiss National Bank Sells 38,400 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Swiss National Bank cut its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 10.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 313,800 shares of the company’s stock after selling 38,400 shares during the period. Swiss National Bank […]

Related Keywords

Switzerland ,Canada ,Swiss ,Williamh Rastetter ,Neurocrine Biosciences ,Eiry Roberts ,Swiss National Bank ,Covestor Ltd ,Acadian Asset Management ,Royal Bank ,Bluepath Capital Management ,Exchange Commission ,Neurocrine Biosciences Inc ,Canaccord Genuity Group ,Bessemer Group Inc ,Neurocrine Biosciences Company Profile ,Kb Financial Partners ,Nasdaq ,Free Report ,National Bank ,Asset Management ,Path Capital Management ,Bessemer Group ,Biosciences Stock Down ,Get Free Report ,Genuity Group ,Director William ,Neurocrine Biosciences Daily ,Nasdaq Nbix ,Nbix ,Medical ,64125c10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,